Literature DB >> 8786307

Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.

M H Newberg1, D H Smith, S B Haertel, D R Vining, E Lacy, V H Engelhard.   

Abstract

The importance of the species of different domains of class I MHC molecules in peripheral T cell recognition and positive and negative selection was evaluated in a single system. In transgenic mice expressing AAD (containing the alpha1+alpha2 domains of HLA-A2.1 and the alpha3 domain of H-2Dd), the CTL response to influenza peptide M1(58-66) in the context of the alpha1+alpha2 domains of HLA-A2.1 was as strong as the influenza-specific H-2Db-restricted response. However, this strong response was only discernible if the target cell MHC molecule also contained a murine alpha3 domain. In contrast, the response in HLA-A2.1 transgenic mice was about 30-fold weaker, and these CTL were indifferent to the origin of the target molecule alpha3 domain. Further analysis suggested that the major impact of the murine alpha3 domain of the transgene product was to enhance positive selection of a low affinity population of AAD-restricted T cells, presumably through species-specific interaction with CD8. Surprisingly, the response to non-self human class I MHC determinants was not augmented in AAD mice, indicating that the T cells selected are narrowly focused on AAD-related structures. Further analysis indicated that the alphal+alpha2 domains as well as the alpha3 domain influenced the magnitude of the response to non-self human class I MHC determinants, and this effect was mapped to alpha2. We suggest that the alpha2 domains of murine class I molecules contain conserved structural elements that augment the avidity of T cell-class I interactions, and this is particularly important in the recognition of non-self MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786307

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Immune predictors of cancer progression.

Authors:  Benjamin Toh; Valerie Chew; Xilei Dai; Karen Khoo; Muly Tham; Lu-En Wai; Sandra Hubert; Sumathy Velumani; Liang Zhi; Caleb Huang; Jean-Pierre Abastado
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.

Authors:  Raktima Bhattacharya; Yan Xu; Md Ashequr Rahman; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Jon A Weidanz; Ulrich Bickel
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

3.  Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors.

Authors:  Katie M Leick; Joel Pinczewski; Ileana S Mauldin; Samuel J Young; Donna H Deacon; Amber N Woods; Marcus W Bosenberg; Victor H Engelhard; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2019-05-27       Impact factor: 6.968

4.  The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.

Authors:  Katie M Leick; Anthony B Rodriguez; Marit M Melssen; Mouadh Benamar; Robin S Lindsay; Rebeka Eki; Kang-Ping Du; Mahmut Parlak; Tarek Abbas; Victor H Engelhard; Craig L Slingluff
Journal:  Ann Surg       Date:  2019-10       Impact factor: 12.969

5.  Immune responses induced in HHD mice by multiepitope HIV vaccine based on cryptic epitope modification.

Authors:  Yinghui Li; Yuxiao Huang; Jiao Liang; Zhikai Xu; Yan Shen; Ning Zhang; Zhongxiang Liu; Ya Zhao
Journal:  Mol Biol Rep       Date:  2013-03-01       Impact factor: 2.316

6.  Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

Authors:  T Arichi; T Saito; M E Major; I M Belyakov; M Shirai; V H Engelhard; S M Feinstone; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Authors:  S Peng; C Trimble; L He; Y-C Tsai; C-T Lin; D A K Boyd; D Pardoll; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2006-01       Impact factor: 5.250

8.  Hepatitis C virus mutation affects proteasomal epitope processing.

Authors:  Ulrike Seifert; Heike Liermann; Vito Racanelli; Anne Halenius; Manfred Wiese; Heiner Wedemeyer; Thomas Ruppert; Kay Rispeter; Peter Henklein; Alice Sijts; Hartmut Hengel; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

9.  Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation.

Authors:  Jarish N Cohen; Cynthia J Guidi; Eric F Tewalt; Hui Qiao; Sherin J Rouhani; Alanna Ruddell; Andrew G Farr; Kenneth S Tung; Victor H Engelhard
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

10.  Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Authors:  James T Snyder; Igor M Belyakov; Amiran Dzutsev; François Lemonnier; Jay A Berzofsky
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.